
RSC Advances p. 30492 - 30499 (2014)
Update date:2022-08-03
Topics:
Yao, Xiaobin
Gong, Yan
Mamuti, Rehangu
Xing, Wenwen
Zheng, Hao
Tang, Xiangyang
Wang, Yong
Isoxazoline derivatives have been disclosed in the art as having acaricidal and insecticidal activity and as potential precursors for the syntheses of natural products. This work first demonstrates the chiral resolution of isoxazoline derivatives that had not been studied before on native cyclodextrin (CD) chiral stationary phases (CSPs). Two structurally well-defined CSPs based on native CD were prepared via different click procedures and applied for the enantioseparation of isoxazolines. Most of the studied isoxazolines were found to be well resolved (Rs > 1.5) under reversed phase mode, especially 4NPh-OPr, which exhibits the best enantioselectivity and resolution (α = 2.22; Rs = 4.16). Optimal resolutions were achieved by evaluating the influences of mobile phase composition, substitution moieties and CSP linkages on the separation. This contribution verifies that excellent enantioseparation of isoxazolines can be accomplished on smartly designed native CD-CSP, which provides a facile and economic way to obtain enantiopure isoxazoline derivatives.
Nanjing Samwon International Limited
Contact:+86-25-84873444
Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
Wuhan Chemchemical Co., Ltd.(expird)
Contact:15973022782
Address:7-5-6218,Incubation Centre,Guandong Industry Park, East Lake High-Tech Development Zone,Wuhan City.
WUXI HONOR SHINE CHEMICAL CO.,LTD
Contact:+86-510-83593312
Address:No.1699 Huishan avenue,Huishan district,Wuxi ,Jiangsu,China,214177.(Wuxi Huishan Ecomonic Develop Zone )
Nanjing lanbai chemical Co.,Ltd.
Contact:+86-25-85499326
Address:Room 908, 9F Taiyue Building,No.285 Heyan Road
website:http://www.vanzpharm.com/en/index.html
Contact:86-27-84492310
Address:FANHU INDUSTRY PARK
Doi:10.1021/jo026285a
(2003)Doi:10.1016/S0040-4020(02)01225-5
(2002)Doi:10.1016/S0968-0896(02)00140-2
(2002)Doi:10.1002/1522-2675(200210)85:10<3422::AID-HLCA3422>3.0.CO;2-N
(2002)Doi:10.1155/2012/802621
(2012)Doi:10.1021/ja029114w
(2003)